← Back to articles

Convertible Note Impact on Cap Table: Conversion Mechanics Decoded

The Convertible Note: Elegant Until It Isn't

Convertible notes are the startup world's favorite gray area. They're debt (technically), but they convert to equity (practically). They defer valuation (delaying hard decisions), but add hidden cap table time bombs (interest accrual, maturity dates, extensions). Founders love them for seed rounds because they're faster to close than priced equity rounds. Investors sometimes tolerate them, but they increasingly demand conversion clarity or convert to structured equity instruments like SAFEs.

The cap table impact is significant and often misunderstood. Your fully diluted cap table must account for all convertible notes as if they were already converted—because at Series A, they will be. This creates a valuation paradox: your Series A price is set based on a post-money valuation, but that valuation already includes the dilution from converting seed notes.

The Mechanics: Discount and Cap

Convertible notes convert to equity using two mechanisms: a discount and a valuation cap. Whichever is more favorable to the note holder typically wins.

The discount mechanism: If you raise your Series A at a $20M post-money valuation, note holders with a 20% discount convert at $16M post-money. Lower conversion price = more shares. This rewards early investors for taking risk without a valuation.

Example: You raised $500K on a convertible note with 20% discount. At Series A, the round is $5M at $20M post-money. The post-money valuation is 20M. The 20% discount price is 20M × 0.8 = $16M post-money. Your Series A investors paid at $20M, but the note converts as if the valuation was $16M—meaning the note holder gets 25% more shares for the same $500K investment.

The valuation cap: A cap sets a maximum effective valuation. If you raise Series A at $50M post-money but your note had a $10M cap, the note converts as if the company was $10M (the capped valuation). This protects early investors from late valuation inflation.

Which mechanism applies? Whichever is lower, hence the most favorable to the note holder. This is why note holders often negotiate aggressively on caps (wanting lower numbers) and discounts (wanting higher percentages).

Calculating Conversion: Step-by-Step Example

Scenario: You raised $500K on a convertible note with 25% discount and $5M cap. Series A: $5M check at $30M post-money valuation.

Step 1: Calculate the post-money valuation. Series A $5M at $30M post-money = yes, this is already given.

Step 2: Apply the discount. Discount valuation = $30M × 0.75 = $22.5M

Step 3: Apply the cap. Capped valuation = $5M

Step 4: Use the lower (more favorable to note holder). $5M cap < $22.5M discount valuation, so use $5M.

Step 5: Calculate conversion price per share. If you have 10M shares outstanding (pre-Series A), then at a $5M valuation, the price per share is $5M / 10M = $0.50/share.

Step 6: Calculate shares issued. $500K / $0.50 = 1M shares.

The note holder receives 1M shares while Series A investors received fewer shares at the higher $30M valuation. This is the entire point of the discount/cap mechanism.

Fully Diluted Cap Table: Accounting for Notes Pre-Conversion

Before Series A closes, your cap table has two forms: Common cap table (shares only) and Fully Diluted cap table (shares plus all convertible instruments).

Common cap table (pre-Series A):

• Founders: 6M shares (60%)
• Employees: 1M shares (10%)
• SAFEs: N/A (SAFEs don't appear as shares until priced round)
• Convertible notes: Not listed
• Total: 7M shares (100%)

Fully diluted cap table (including convertible notes):

• Founders: 6M shares (50%)
• Employees: 1M shares (8.3%)
• Note holders (converted): 2M shares (16.7%)
• Option pool (reserved): 1.5M shares (12.5%)
• SAFEs (assumed conversion): 2M shares (16.7%) — if you raised $1M on SAFEs
• Total: 12M shares (100%)

The fully diluted includes everything that could become shares. This is the number investors use when evaluating dilution from hiring plans, option pools, and future rounds. If you tell a Series A investor you have 7M shares outstanding but your fully diluted is 12M, that's a critical gap in the conversation.

The Interest and Maturity Trap

Convertible notes accrue interest (typically 5-8% annually) and have maturity dates (usually 24-36 months). If you haven't raised Series A by the maturity date, the note becomes due as debt. This creates pressure.

Interest impact on conversion: Accrued interest gets rolled into the note amount at conversion. So your $500K note becomes $500K + accrued interest (~$40-60K over 2 years) = $540-560K converted to shares. This is another small dilution hidden in the conversion mechanics.

Maturity date pressure: If your note matures in 24 months and you haven't raised Series A, you owe the full amount back. Many founders extend notes rather than return capital. Extensions add more interest and complexity. Be clear on maturity dates when you accept capital.

Multiple Notes on One Cap Table: Complexity Multiplies

Most seed rounds involve multiple convertible notes—different angels, friends and family, accelerators. Each note has its own discount and cap. When Series A closes, each converts differently.

Example with two notes:

• Note 1: $200K, 20% discount, $4M cap
• Note 2: $300K, 25% discount, $6M cap
• Series A: $5M at $30M post-money

For Note 1: Discount = $22.5M, Cap = $4M → use $4M → price = $0.40/share (if 10M baseline) → 500K shares

For Note 2: Discount = $22.5M, Cap = $6M → use $6M → price = $0.60/share → 500K shares

Same Series A round, but different note holders receive different effective prices. Series A investors and founders end up with a cleaner, uniform structure, but pre-Series A cap table is a mess. This is manageable for 2-3 notes; with 10+ notes it becomes a compliance nightmare.

SAFEs vs. Convertible Notes: Cap Table Mechanics Differ

SAFEs (Simplified Agreements for Future Equity) are gaining popularity because they're simpler than convertible notes. But their cap table impact differs.

Unlike convertible notes, SAFEs don't accrue interest and have no maturity dates. They also don't appear on your cap table pre-priced round (they're not shares). At Series A, they convert similarly to convertible notes (discount and cap), but the pre-Series A cap table is cleaner.

Key difference: If you have $500K in convertible notes and $300K in SAFEs raising on the same terms, your fully diluted cap table must account for both. But if the note matures before Series A, you have a ticking deadline. SAFEs give you more flexibility.

Cap Table Strategy: Managing Note Conversion

Keep note terms standardized. If you raise $1M across multiple notes, try to use the same discount and cap. This simplifies Series A conversion and makes your cap table legible to investors.

Negotiate caps thoughtfully at seed. A $2M cap signals you expect early success but realistic growth. A $10M cap gives investors more breathing room. Balance investor expectations (they want favorable conversion terms) with your own dilution concerns.

Plan for Series A valuation. If you raise $500K at a $2M cap, and you later raise Series A at $50M, the $2M cap holder gets a 25x multiple (they convert at a $2M valuation when the round price is $50M). This seems unfair in hindsight but was fair when they took the risk at seed. Explain this to Series A investors—they'll understand the mechanic.

Document everything. With multiple notes, keep a master schedule listing amount, discount, cap, maturity date, and interest rate for each. Share this with your Series A investors so they understand the full dilution picture.

Key Takeaways

• Convertible notes convert to equity using discount (20-30% typical) and cap (varies by stage)
• The lower of discount-valuation or cap-valuation is used in conversion—more favorable to note holder
• Fully diluted cap table must include all convertible notes as future shares
• Interest accrues on notes and is included in conversion amount (increases dilution slightly)
• Maturity dates create pressure; plan for Series A before maturity or extend notes
• Multiple notes with different terms compound complexity; standardize when possible
• SAFEs are simpler (no interest, no maturity) but convert using the same discount/cap mechanics

Frequently Asked Questions

If a note has a discount and cap, how do I know which one will apply at Series A?

Whichever is lower (more favorable to the note holder). If your discount gives a $18M effective valuation and your cap is $10M, the cap wins. You can model scenarios at your expected Series A valuation ($30M, $50M, etc.) to see which mechanism will likely apply.

Can I convert a note to equity early, before Series A?

Yes, though it requires all note holders' consent. Some founders want to clean up their cap table pre-Series A by converting notes to equity. This triggers valuation issues (you need a priced round or 409A valuation to set a price) and may require unanimous consent depending on your note terms.

What if Series A investors don't want to use my note terms at conversion?

Series A investors will push back if note caps are too high or discounts too generous. You'll negotiate. But the note agreements are binding—you can't unilaterally change them. What you can do: get written consent from note holders to adjust terms, or absorb the cost in founder dilution if you want to make the Series A cleaner. Most notes convert as-written.

Should I be worried about the fully diluted dilution from notes?

It's important to understand it, but not to panic. Yes, note holders will own more shares per dollar than Series A investors, but that's the trade-off of early capital at uncertain valuation. Series A investors account for this. What matters is that you're transparent in your cap table and realistic about the final fully-diluted ownership after conversion.

Do convertible notes have anti-dilution clauses?

Most YC-style notes do not include weighted-average anti-dilution (that's for preferred equity, not debt). Some longer-form notes might include broad-based anti-dilution. Check your note terms. If notes include anti-dilution, it'll affect your Series A dilution calculation—another reason to standardize note terms across investors.